These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6813334)

  • 1. The durability of inactivated poliovirus vaccine: studies on the stability of potency in vivo and in vitro.
    Moynihan M; Petersen I
    J Biol Stand; 1982 Jul; 10(3):261-8. PubMed ID: 6813334
    [No Abstract]   [Full Text] [Related]  

  • 2. Sera collected before introduction of contaminated polio vaccine contain antibodies against SV40.
    Geissler E; Konzer P; Scherneck S; Zimmermann W
    Acta Virol; 1985 Sep; 29(5):420-3. PubMed ID: 2866697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).
    Rezapkin G; Dragunsky E; Chumakov K
    Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
    Rezapkin G; Martin J; Chumakov K
    Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of a physical method for the quantification of inactivated poliovirus particles and its relationship to D-antigenicity and potency testing in rats.
    Doel TR; Osterhaus AD; van Wezel AL; van Steenis G
    J Biol Stand; 1984 Jan; 12(1):93-9. PubMed ID: 6699027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
    Singer C; Knauert F; Bushar G; Klutch M; Lundquist R; Quinnan GV
    J Biol Stand; 1989 Apr; 17(2):137-50. PubMed ID: 2541133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-linked immunosorbent assay for detection of poliovirus antigen and antibody.
    Moynihan M; Ladefoged P; Mathiesen L
    Dev Biol Stand; 1980; 46():203-6. PubMed ID: 6244998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.
    Verdijk P; Rots NY; van Oijen MG; Oberste MS; Boog CJ; Okayasu H; Sutter RW; Bakker WA
    Vaccine; 2013 Nov; 31(47):5531-6. PubMed ID: 24063976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avidity and titers of the antibody response to two inactivated poliovirus vaccines with different antigen content.
    Mellander L; Böttiger M; Hanson LA; Taranger J; Carlsson B
    Acta Paediatr; 1993; 82(6-7):552-6. PubMed ID: 8393360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deleterious effect of thimerosal on the potency of inactivated poliovirus vaccine.
    Sawyer LA; McInnis J; Patel A; Horne AD; Albrecht P
    Vaccine; 1994 Jul; 12(9):851-6. PubMed ID: 7526574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants.
    Adenyi-Jones SC; Faden H; Ferdon MB; Kwong MS; Ogra PL
    J Pediatr; 1992 May; 120(5):686-9. PubMed ID: 1315853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum and salivary antibodies in children vaccinated with oral live or parenteral inactivated poliovirus vaccines of different antigen concentrations.
    Zaman S; Carlsson B; Jalil F; Mellander L; Van Wezel AL; Böttiger M; Hanson LA
    Acta Paediatr Scand; 1991 Dec; 80(12):1166-73. PubMed ID: 1785289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic structure of poliovirus in inactivated vaccines.
    Ferguson M; Wood DJ; Minor PD
    J Gen Virol; 1993 Apr; 74 ( Pt 4)():685-90. PubMed ID: 7682250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory and serum immunoglobulin class-specific antibodies to poliovirus after vaccination.
    Carlsson B; Zaman S; Mellander L; Jalil F; Hanson LA
    J Infect Dis; 1985 Dec; 152(6):1238-44. PubMed ID: 2999260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chromatographic determination of polio antibodies in IgG and IgM fractions of the serum and comparison of results with the neutralization test].
    Szöllösy E; Petheö G; Hils J; Böthig B
    Acta Microbiol Acad Sci Hung; 1972; 19(1):55-61. PubMed ID: 4346733
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
    Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF
    J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of methods for intratypic differentiation of polioviruses. II. Use of strain-specific antisera cross-adsorbed with antigens of heterologous strains in agar gel diffusion precipitation test for differentiation between wild and vaccine strains of poliovirus typess 1,2 and 3.
    Rubin SG; Chumakov MP; Savinskaya SS; Pervikov YV; Gracheva LA; Voroshilova MK
    Arch Gesamte Virusforsch; 1974; 46(1-2):66-70. PubMed ID: 4374168
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement of methods for intratypic differentiation of polioviruses. III. Neutralization test with cross-adsorbed sera for differentiation between wild and vaccine strains of polioviruses.
    Pervikov YV; Chumakov MP; Voroshilova MK; Rubin SG; Savinskaya SS; Gracheva LA
    Arch Gesamte Virusforsch; 1974; 46(1-2):71-7. PubMed ID: 4374169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.